Stay updated on ABP 959 vs Eculizumab in PNH: Clinical Trial
Sign up to get notified when there's something new on the ABP 959 vs Eculizumab in PNH: Clinical Trial page.

Latest updates to the ABP 959 vs Eculizumab in PNH: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record for the ABP 959 versus eculizumab trial in adults with PNH is available again, with detailed study information and posted results. It also includes publication and data-sharing information, study documents, and links to Amgen resources.SummaryDifference70%

- Check17 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0 while the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces NIH website transition updates and says that, under Executive Order 14434, NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe site revision in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record with an access-denied screen. It also removes most study content and Amgen-related documents from view.SummaryDifference20%

Stay in the know with updates to ABP 959 vs Eculizumab in PNH: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 959 vs Eculizumab in PNH: Clinical Trial page.